Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · IEX Real-Time Price · USD
11.31
-0.26 (-2.25%)
At close: Jul 26, 2024, 1:13 PM
12.05
+0.74 (6.54%)
After-hours: Jul 26, 2024, 7:10 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $11.93 million as of July 26, 2024. Its market cap has increased by 159.43% in one year.
Market Cap
11.93M
Enterprise Value
-98.25M
1-Year Change
159.43%
Ranking
Category
Stock Price
$11.31
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has decreased from $34.50M to $11.93M, a decrease of -65.41%. That is a compound annual growth rate of -11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 12.00M | 64.38% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Integrated Sciences | 13.13M |
| Ontrak | 12.98M |
| Universe Pharmaceuticals INC | 12.94M |
| Addex Therapeutics | 12.93M |
| BriaCell Therapeutics | 12.87M |
| Lumos Pharma | 12.42M |
| Guardion Health Sciences | 12.39M |
| Kintara Therapeutics | 12.27M |